Filip Zemrak
Overview
Explore the profile of Filip Zemrak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahtani K, MacLean E, Parker M, Vyas R, Wang R, Roelas M, et al.
Br J Cardiol
. 2024 Nov;
31(2):024.
PMID: 39555470
In ambulatory patients with complete heart block (CHB), dual-chamber (DDD) pacing confers physiological benefits versus single-chamber (VVI) pacing, however, the impact on mortality is disputed. Nonagenarians constitute an expanding proportion...
2.
Neijenhuis R, MacDonald S, Zemrak F, Mertens B, Dinsdale A, Hunter A, et al.
J Am Coll Cardiol
. 2024 Mar;
83(15):1403-1414.
PMID: 38530688
Background: Heart failure (HF) is the principal cause of morbidity and mortality in adults with congenital heart disease (ACHD). Robust evidence-based treatment options are lacking. Objectives: This study aims to...
3.
Fauvel C, Bonnet G, Mullens W, Giraldo C, Meznar A, Barasa A, et al.
Eur J Heart Fail
. 2022 Nov;
25(2):213-222.
PMID: 36404398
Aims: In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent international guidelines recommend initiating four major therapeutic classes rather than sequential initiation. It remains unclear how this...
4.
Rosmini S, Seraphim A, Knott K, Brown J, Knight D, Zaman S, et al.
Eur Heart J Cardiovasc Imaging
. 2021 Jul;
23(8):1117-1126.
PMID: 34331054
Aims: Differentiating exudative from transudative effusions is clinically important and is currently performed via biochemical analysis of invasively obtained samples using Light's criteria. Diagnostic performance is however limited. Biochemical composition...
5.
Bajaj R, Sinclair H, Patel K, Low B, Pericao A, Manisty C, et al.
Lancet Respir Med
. 2021 Feb;
9(4):e32-e34.
PMID: 33617781
No abstract available.
6.
Ricci F, Aung N, Gallina S, Zemrak F, Fung K, Bisaccia G, et al.
J Cardiovasc Magn Reson
. 2021 Jan;
23(1):5.
PMID: 33407573
Background: Mitral valve (MV) and tricuspid valve (TV) apparatus geometry are essential to define mechanisms and etiologies of regurgitation and to inform surgical or transcatheter interventions. Given the increasing use...
7.
Zemrak F, Raisi-Estabragh Z, Khanji M, Mohiddin S, Bruder O, Wagner A, et al.
Front Cardiovasc Med
. 2020 Nov;
7:158.
PMID: 33195445
Left ventricular non-compaction (LVNC) is perceived as a rare high-risk cardiomyopathy characterized by excess left ventricular (LV) trabeculation. However, there is increasing evidence contesting the clinical significance of LV hyper-trabeculation...
8.
Aung N, Doimo S, Ricci F, Sanghvi M, Pedrosa C, Woodbridge S, et al.
Circ Cardiovasc Imaging
. 2020 Jan;
13(1):e009712.
PMID: 31959004
Background: Although left ventricular noncompaction (LVNC) has been associated with an increased risk of adverse cardiovascular events, the accurate incidence of cardiovascular morbidity and mortality is unknown. We, therefore, aimed...
9.
Khanji M, Jensen M, Kenawy A, Raisi-Estabragh Z, Paiva J, Aung N, et al.
JACC Cardiovasc Imaging
. 2019 Dec;
13(3):886-888.
PMID: 31864983
No abstract available.
10.
Mangan C, Zemrak F, Banerjee A, Bhattacharyya S, Treibel T, Lloyd G
Eur Heart J Qual Care Clin Outcomes
. 2019 Nov;
7(6):616-617.
PMID: 31782773
No abstract available.